Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 5
2022 2
2023 3
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Household immunity and individual risk of infection with dengue virus in a prospective, longitudinal cohort study.
Hamins-Puértolas M, Buddhari D, Salje H, Cummings DAT, Fernandez S, Farmer A, Kaewhiran S, Khampaen D, Iamsirithaworn S, Srikiatkhachorn A, Waickman A, Thomas SJ, Rothman AL, Endy T, Rodriguez-Barraquer I, Anderson KB. Hamins-Puértolas M, et al. Nat Microbiol. 2024 Jan;9(1):274-283. doi: 10.1038/s41564-023-01543-3. Epub 2023 Dec 18. Nat Microbiol. 2024. PMID: 38110699 Free PMC article.
Seroprevalence of Antibodies to SARS-CoV-2 in Rural Households in Eastern Uganda, 2020-2022.
Briggs J, Takahashi S, Nayebare P, Cuu G, Rek J, Zedi M, Kizza T, Arinaitwe E, Nankabirwa JI, Kamya M, Jagannathan P, Jacobson K, Rosenthal PJ, Dorsey G, Greenhouse B, Ssewanyana I, Rodríguez-Barraquer I. Briggs J, et al. JAMA Netw Open. 2023 Feb 1;6(2):e2255978. doi: 10.1001/jamanetworkopen.2022.55978. JAMA Netw Open. 2023. PMID: 36790811 Free PMC article.
Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2.
Routledge I, Takahashi S, Epstein A, Hakim J, Janson O, Turcios K, Vinden J, Risos JT, Baniqued MR, Pham L, Di Germanio C, Busch M, Kushel M, Greenhouse B, Rodríguez-Barraquer I. Routledge I, et al. medRxiv [Preprint]. 2021 Oct 20:2021.10.06.21264573. doi: 10.1101/2021.10.06.21264573. medRxiv. 2021. Update in: Nat Commun. 2022 May 4;13(1):2451. doi: 10.1038/s41467-022-30051-x PMID: 34642695 Free PMC article. Updated. Preprint.
Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records.
Routledge I, Epstein A, Takahashi S, Janson O, Hakim J, Duarte E, Turcios K, Vinden J, Sujishi K, Rangel J, Coh M, Besana L, Ho WK, Oon CY, Ong CM, Yun C, Lynch K, Wu AHB, Wu W, Karlon W, Thornborrow E, Peluso MJ, Henrich TJ, Pak JE, Briggs J, Greenhouse B, Rodriguez-Barraquer I. Routledge I, et al. Nat Commun. 2021 Jun 11;12(1):3566. doi: 10.1038/s41467-021-23651-6. Nat Commun. 2021. PMID: 34117227 Free PMC article.
SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency.
Takahashi S, Peluso MJ, Hakim J, Turcios K, Janson O, Routledge I, Busch MP, Hoh R, Tai V, Kelly JD, Martin JN, Deeks SG, Henrich TJ, Greenhouse B, Rodríguez-Barraquer I. Takahashi S, et al. medRxiv [Preprint]. 2021 Sep 14:2021.09.09.21263139. doi: 10.1101/2021.09.09.21263139. medRxiv. 2021. Update in: Am J Epidemiol. 2023 Sep 1;192(9):1562-1575. doi: 10.1093/aje/kwad106 PMID: 34545373 Free PMC article. Updated. Preprint.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, Rodgers MA, Prostko J, Hackett J Jr, Trinh L, Wrin T, Petroplolous CJ, Chiu CY, Norris PJ, DiGermanio C, Stone M, Busch MP, Elledge SK, Zhou XX, Wells JA, Shu A, Kurtz TW, Pak JE, Wu W, Burbelo PD, Cohen JI, Rutishauser RL, Martin JN, Deeks SG, Henrich TJ, Rodriguez-Barraquer I, Greenhouse B. Peluso MJ, et al. medRxiv [Preprint]. 2021 Mar 5:2021.03.03.21251639. doi: 10.1101/2021.03.03.21251639. medRxiv. 2021. Update in: Sci Adv. 2021 Jul 30;7(31):eabh3409. doi: 10.1126/sciadv.abh3409 PMID: 33688675 Free PMC article. Updated. Preprint.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Donatelli J, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, Rodgers MA, Prostko J, Hackett J Jr, Trinh L, Wrin T, Petropoulos CJ, Chiu CY, Norris PJ, DiGermanio C, Stone M, Busch MP, Elledge SK, Zhou XX, Wells JA, Shu A, Kurtz TW, Pak JE, Wu W, Burbelo PD, Cohen JI, Rutishauser RL, Martin JN, Deeks SG, Henrich TJ, Rodriguez-Barraquer I, Greenhouse B. Peluso MJ, et al. Sci Adv. 2021 Jul 30;7(31):eabh3409. doi: 10.1126/sciadv.abh3409. Print 2021 Jul. Sci Adv. 2021. PMID: 34330709 Free PMC article.
Reconstructing the SARS-CoV-2 epidemic in eastern Uganda through longitudinal serosurveillance in a malaria cohort.
Briggs J, Takahashi S, Nayebare P, Cuu G, Rek J, Zedi M, Kizza T, Arinaitwe E, Nankabirwa JI, Kamya M, Jagannathan P, Jacobson K, Rosenthal PJ, Dorsey G, Greenhouse B, Ssewanyana I, Rodríguez-Barraquer I. Briggs J, et al. medRxiv [Preprint]. 2022 Sep 21:2022.09.20.22280170. doi: 10.1101/2022.09.20.22280170. medRxiv. 2022. PMID: 36172117 Free PMC article. Preprint.
SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency.
Takahashi S, Peluso MJ, Hakim J, Turcios K, Janson O, Routledge I, Busch MP, Hoh R, Tai V, Kelly JD, Martin JN, Deeks SG, Henrich TJ, Greenhouse B, Rodríguez-Barraquer I. Takahashi S, et al. Am J Epidemiol. 2023 Sep 1;192(9):1562-1575. doi: 10.1093/aje/kwad106. Am J Epidemiol. 2023. PMID: 37119030 Free PMC article.